{"body":"<p>While certain tools might have been approved and recommended by stringent regulatory authorities, evaluation of their safety might still be warranted if they are to be used at scale or in asymptomatic populations. Recent examples include evaluation of the RTS,S vaccine (as per the WHO recommendation) and pharmacovigilance for the use of ACT in mass drug administration trials. Evaluations of safety should take into consideration the risks and benefits of the tool in the context of use (e.g. medicines for malaria treatment and for mass drug administration).<\/p>&#13;\n","title":"6.2.2 Safety","nid":359,"vid":789,"created":1567506471,"changed":1568360123,"field_content_type":{"tid":2,"name":"Content","class":"content"},"field_references":null}